Peters et al. investigated the relationship between the gut microbiome and immunotherapy response (anti-PD-1 and anti-CTLA-4) in melanoma patients and found that a high abundance of Ruminococcus gnavus was related to shorter PFS [34]. This evidence concerns the gene CTLA4 and melanoma.